Suchergebnisse - "Cavallari, Larisa H"

PubPharm (73)

1

A pilot study to identify pharmacogenomic and clinical risk factors associated with opioid related falls and adverse effects in older adults

enthalten in: Clinical and translational science | 2023

von Sheikh, S. | Fernandez, R. | Smotherman, C. | +10

2

CYP3A4 and CYP3A5 Genotyping Recommendations : A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase

enthalten in: The Journal of molecular diagnostics : JMD | 2023

von Pratt, V. | Cavallari, L. | Fulmer, M. | +10

3

Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention

enthalten in: Clinical pharmacology and therapeutics | 2023

von Cavallari, L. | Limdi, N. | Beitelshees, A. | +19

4

Local Ancestry-Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations

enthalten in: Clinical pharmacology and therapeutics | 2023

von Steiner, H. | Carrion, K. | Giles, J. | +7

5

TPMT and NUDT15 Genotyping Recommendations : A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase

enthalten in: The Journal of molecular diagnostics : JMD | 2022

von Pratt, V. | Cavallari, L. | Fulmer, M. | +10

6

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome : a network meta-analysis of 61 898 patients from 15 randomized trials

enthalten in: European heart journal | 2022

von Galli, M. | Benenati, S. | Franchi, F. | +13

CommentIn: Eur Heart J. 2022 Mar 7;43(10):968-970. - PMID 35166344

7

CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings

enthalten in: Journal of the American Heart Association | 2022

von Beitelshees, A. | Thomas, C. | Empey, P. | +22

8

Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers

enthalten in: The pharmacogenomics journal | 2022

von Guerra, L. | Lteif, C. | Arwood, M. | +5

9

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

enthalten in: Clinical and translational science | 2022

von Tuteja, S. | Salloum, R. | Elchynski, A. | +26

10

Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2021

von Duarte, J. | Dalton, R. | Elchynski, A. | +19

1
2
3
4
5
6
7
8
Nächster »
[8]